Opportunity Information: Apply for PA 17 198

The grant opportunity titled "Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R03)" aims to promote innovative research into substance use among individuals aged 50 and older. Despite advancements in substance use disorder research, the factors and impacts related to drug use in later life are not well understood. This funding initiative encourages studies that explore the reasons behind the use of marijuana, opioids, and benzodiazepines in older adults, as well as the neurobiological changes, behaviors, and public health implications associated with this use.

The focus is on two groups: those who have used drugs earlier in life and are now aging, and those who begin using drugs after the age of 50. Researchers are urged to employ diverse methodologies, including basic science, clinical studies, and epidemiological approaches. The findings from this research are expected to provide valuable insights into risk factors and inform clinical practices tailored to older populations.

Various institutions and organizations are eligible to apply for this grant, including those that serve specific communities such as Alaska Native and Native Hawaiian populations, Hispanic-serving institutions, Historically Black Colleges and Universities, and more. The initiative reflects a commitment to understanding and addressing drug use in the aging population to improve public health outcomes.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R03)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279, 93.866.
  • This funding opportunity was created on 2017-03-07.
  • Applicants must submit their applications by 2018-01-24. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2025.)
  • Each selected applicant is eligible to receive up to $50,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PA 17 198

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Maximizing Technology Commercialization of Federal Research Investments through the Best Practices at Innovation and Economic Prosperity Universities

Previous opportunity: Supplemental and Alternative Crops Competitive Grants Program

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 17 198

 

Applicants also applied for:

Applicants who have applied for this opportunity (PA 17 198) also looked into and applied for these:

Funding Opportunity
Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R21) Apply for PA 17 197

Funding Number: PA 17 197
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Inter-organelle Communication in Cancer (R21) Apply for PAR 17 204

Funding Number: PAR 17 204
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Inter-organelle Communication in Cancer (R01) Apply for PAR 17 203

Funding Number: PAR 17 203
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1) Apply for RFA DA 18 001

Funding Number: RFA DA 18 001
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Alliance of Glycobiologists for Cancer Research: Translational Tumor Glycomics Laboratories (U01) Apply for PAR 17 206

Funding Number: PAR 17 206
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Alliance of Glycobiologists for Cancer Research: Biological Tumor Glycomics Laboratories (U01) Apply for PAR 17 207

Funding Number: PAR 17 207
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Mechanisms of Alcohol-associated Cancers (R21) Apply for PA 17 219

Funding Number: PA 17 219
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Mechanisms of Alcohol-associated Cancers (R01) Apply for PA 17 220

Funding Number: PA 17 220
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Revision Applications to National Cancer Institute (NCI)-supported U01 Awards to Include Research on the NCI's Provocative Questions (U01) Apply for RFA CA 17 020

Funding Number: RFA CA 17 020
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
Revision Applications to National Cancer Institute (NCI)-supported P01 Awards to Include Research on the NCI's Provocative Questions (P01) Apply for RFA CA 17 021

Funding Number: RFA CA 17 021
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
Revision Applications to National Cancer Institute (NCI)-supported P50 Awards to Include Research on the NCI's Provocative Questions (P50) Apply for RFA CA 17 022

Funding Number: RFA CA 17 022
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
Revision Applications to NCI-supported R01 Awards to Include Research on the NCI's Provocative Questions (R01) Apply for RFA CA 17 019

Funding Number: RFA CA 17 019
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
Supplements for Validating the Use of Automated Sources of Residential Histories in Cancer Epidemiology Cohorts (Admin Supp) Apply for PA 17 222

Funding Number: PA 17 222
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $125,000
Research Supplements to Promote Sharing Data in Cancer Epidemiology Studies (Admin Supp) Apply for PA 17 224

Funding Number: PA 17 224
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $100,000
Supplement Opportunity to Support Population-Based Research Studies of Rare Cancers (Admin Supp) Apply for PA 17 223

Funding Number: PA 17 223
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
Advancing the Science of Geriatric Palliative Care (R01) Apply for PA 17 225

Funding Number: PA 17 225
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Advancing the Science of Geriatric Palliative Care (R21) Apply for PA 17 226

Funding Number: PA 17 226
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01) Apply for PAR 17 233

Funding Number: PAR 17 233
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,250,000
Mechanisms and Consequences of Sleep Disparities in the U.S. (R21) Apply for PAR 17 235

Funding Number: PAR 17 235
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Innovative Research in Cancer Nanotechnology (IRCN) (R01) Apply for PAR 17 240

Funding Number: PAR 17 240
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $450,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 17 198", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: